SCHEMBL5282157

SCHEMBL5282157

CC(C)=NN=c1sc2ccccc2n1Cc1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
P2RX4 Q99571 1/20 0.42
RECQL P46063 1/20 0.41
MAPK10 P53779 1/20 0.41
ALDH1A1 P00352 5/20 0.41
TSHR P16473 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TP53 P04637 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282152 1.00 SMN1; SMN2 (0.43) SMN1; SMN2TDP1L3MBTL1KDM4EPKM
SCHEMBL4615041 0.81 SMN1; SMN2 (0.47) SMN1; SMN2TDP1L3MBTL1KDM4EPKM
SCHEMBL5282522 0.81 NPSR1 (0.55) SMN1; SMN2PKMMAPK1KMT2AMEN1
SCHEMBL5282524 0.81 NPSR1 (0.55) SMN1; SMN2PKMMAPK1KMT2AMEN1
SCHEMBL5708513 0.79 KMT2A (0.60) SMN1; SMN2TDP1L3MBTL1KDM4EPKM
SCHEMBL5284142 0.79 CNR1 (0.46) SMN1; SMN2L3MBTL1MAPK1KMT2AMEN1
SCHEMBL5284148 0.79 CNR1 (0.46) SMN1; SMN2L3MBTL1MAPK1KMT2AMEN1
SCHEMBL5283843 0.79 MAPT (0.45) SMN1; SMN2L3MBTL1MAPK1KMT2AMEN1
SCHEMBL5283710 0.77 MAPT (0.44) SMN1; SMN2L3MBTL1MAPK1KMT2AMEN1
SCHEMBL5284131 0.76 CNR1 (0.52) SMN1; SMN2MAPK1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT SMN1; SMN2 3523/4885TDP1 4136/4885L3MBTL1 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.